Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fractional Flow Reserve, Myocardial | 40 | 2024 | 346 | 8.100 |
Why?
|
Coronary Stenosis | 27 | 2023 | 798 | 4.220 |
Why?
|
Coronary Artery Disease | 33 | 2024 | 6544 | 2.570 |
Why?
|
Coronary Vessels | 28 | 2023 | 3094 | 2.440 |
Why?
|
Hyperemia | 13 | 2022 | 223 | 1.950 |
Why?
|
Coronary Circulation | 9 | 2020 | 1601 | 1.730 |
Why?
|
Drug-Eluting Stents | 9 | 2024 | 680 | 1.540 |
Why?
|
Coronary Angiography | 34 | 2024 | 4498 | 1.430 |
Why?
|
Microcirculation | 15 | 2021 | 1282 | 1.150 |
Why?
|
Coronary Sinus | 4 | 2022 | 85 | 1.120 |
Why?
|
Troponin I | 3 | 2019 | 656 | 1.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 5 | 2021 | 1093 | 0.980 |
Why?
|
Predictive Value of Tests | 34 | 2024 | 15401 | 0.860 |
Why?
|
Amino Acids, Branched-Chain | 2 | 2022 | 266 | 0.790 |
Why?
|
Transducers, Pressure | 2 | 2019 | 52 | 0.760 |
Why?
|
Tooth Loss | 1 | 2023 | 198 | 0.730 |
Why?
|
Cardiovascular Diseases | 6 | 2024 | 15645 | 0.710 |
Why?
|
Methylamines | 1 | 2020 | 136 | 0.670 |
Why?
|
Tomography, Optical Coherence | 14 | 2020 | 2876 | 0.660 |
Why?
|
Plaque, Atherosclerotic | 10 | 2022 | 1529 | 0.660 |
Why?
|
Neointima | 5 | 2019 | 133 | 0.650 |
Why?
|
Vascular Resistance | 10 | 2020 | 939 | 0.650 |
Why?
|
Catheter Ablation | 5 | 2019 | 2787 | 0.640 |
Why?
|
Blood Flow Velocity | 8 | 2022 | 1377 | 0.620 |
Why?
|
Pericardiocentesis | 1 | 2018 | 78 | 0.610 |
Why?
|
Acute Coronary Syndrome | 6 | 2020 | 2185 | 0.610 |
Why?
|
Cholesterol, HDL | 2 | 2022 | 1813 | 0.590 |
Why?
|
Cardiac Tamponade | 1 | 2018 | 175 | 0.560 |
Why?
|
Severity of Illness Index | 17 | 2022 | 15878 | 0.530 |
Why?
|
Metabolomics | 2 | 2024 | 1667 | 0.500 |
Why?
|
Diet, Mediterranean | 1 | 2022 | 746 | 0.490 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2024 | 12235 | 0.490 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2020 | 698 | 0.490 |
Why?
|
Walking | 1 | 2022 | 1198 | 0.480 |
Why?
|
Body Temperature | 1 | 2018 | 781 | 0.470 |
Why?
|
Catheters | 1 | 2017 | 427 | 0.470 |
Why?
|
Regional Blood Flow | 1 | 2018 | 1479 | 0.460 |
Why?
|
Polytetrafluoroethylene | 1 | 2015 | 242 | 0.450 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2020 | 669 | 0.450 |
Why?
|
PPAR-beta | 1 | 2013 | 4 | 0.440 |
Why?
|
PPAR delta | 1 | 2013 | 40 | 0.430 |
Why?
|
Lipid Metabolism | 1 | 2021 | 1893 | 0.410 |
Why?
|
Middle Aged | 51 | 2024 | 223016 | 0.400 |
Why?
|
Aged | 51 | 2024 | 171163 | 0.400 |
Why?
|
Pulmonary Edema | 1 | 2015 | 409 | 0.400 |
Why?
|
Prognosis | 20 | 2023 | 29890 | 0.400 |
Why?
|
Treatment Outcome | 31 | 2024 | 65194 | 0.380 |
Why?
|
Cholesterol, LDL | 1 | 2021 | 2395 | 0.380 |
Why?
|
Intraoperative Complications | 1 | 2018 | 1169 | 0.380 |
Why?
|
Cardiology | 1 | 2023 | 1696 | 0.380 |
Why?
|
Registries | 10 | 2024 | 8346 | 0.360 |
Why?
|
Sodium, Dietary | 2 | 2024 | 426 | 0.350 |
Why?
|
I-kappa B Kinase | 1 | 2012 | 249 | 0.350 |
Why?
|
Humans | 87 | 2024 | 765926 | 0.340 |
Why?
|
Exercise | 2 | 2024 | 5936 | 0.340 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2018 | 1735 | 0.330 |
Why?
|
Japan | 5 | 2020 | 1411 | 0.330 |
Why?
|
Blood Pressure | 4 | 2024 | 8530 | 0.330 |
Why?
|
Male | 57 | 2024 | 363815 | 0.320 |
Why?
|
Sodium | 2 | 2024 | 1591 | 0.310 |
Why?
|
Female | 56 | 2024 | 396141 | 0.310 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3444 | 0.310 |
Why?
|
Graft Occlusion, Vascular | 1 | 2012 | 539 | 0.300 |
Why?
|
Vascular System Injuries | 1 | 2012 | 245 | 0.300 |
Why?
|
Hypertension | 4 | 2024 | 8616 | 0.300 |
Why?
|
Femoral Artery | 1 | 2012 | 825 | 0.280 |
Why?
|
Ultrasonography, Interventional | 4 | 2020 | 1519 | 0.280 |
Why?
|
Insulin Resistance | 1 | 2021 | 3988 | 0.280 |
Why?
|
Angioplasty, Balloon, Coronary | 3 | 2017 | 1721 | 0.280 |
Why?
|
Republic of Korea | 4 | 2024 | 583 | 0.270 |
Why?
|
Hemodynamics | 4 | 2021 | 4186 | 0.260 |
Why?
|
Benzamides | 1 | 2012 | 1376 | 0.260 |
Why?
|
Thiazoles | 1 | 2013 | 1528 | 0.250 |
Why?
|
Peptide Fragments | 1 | 2018 | 5126 | 0.250 |
Why?
|
Risk Factors | 19 | 2024 | 74850 | 0.240 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11508 | 0.240 |
Why?
|
Rest | 2 | 2020 | 940 | 0.230 |
Why?
|
Reproducibility of Results | 10 | 2024 | 20133 | 0.230 |
Why?
|
Potassium, Dietary | 1 | 2024 | 103 | 0.220 |
Why?
|
Aortic Diseases | 2 | 2020 | 741 | 0.220 |
Why?
|
Baroreflex | 1 | 2024 | 153 | 0.220 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5889 | 0.220 |
Why?
|
Telemedicine | 1 | 2021 | 3108 | 0.220 |
Why?
|
Adipose Tissue | 5 | 2021 | 3314 | 0.210 |
Why?
|
Cryosurgery | 2 | 2019 | 479 | 0.210 |
Why?
|
Diet | 1 | 2020 | 8087 | 0.200 |
Why?
|
Inflammation | 8 | 2023 | 10843 | 0.200 |
Why?
|
Electrocardiography | 5 | 2021 | 6409 | 0.200 |
Why?
|
Pulmonary Veins | 2 | 2019 | 757 | 0.200 |
Why?
|
Stents | 5 | 2020 | 3191 | 0.200 |
Why?
|
Thermodilution | 2 | 2021 | 50 | 0.200 |
Why?
|
Spain | 2 | 2020 | 483 | 0.190 |
Why?
|
Time Factors | 13 | 2024 | 40097 | 0.190 |
Why?
|
Urinalysis | 1 | 2024 | 369 | 0.190 |
Why?
|
Magnetic Resonance Angiography | 2 | 2018 | 1429 | 0.190 |
Why?
|
Equipment Design | 3 | 2019 | 3490 | 0.190 |
Why?
|
Shellfish | 1 | 2020 | 37 | 0.180 |
Why?
|
Preoperative Period | 2 | 2020 | 565 | 0.180 |
Why?
|
Postoperative Period | 3 | 2020 | 1818 | 0.180 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2022 | 353 | 0.180 |
Why?
|
Atrial Fibrillation | 4 | 2021 | 5186 | 0.170 |
Why?
|
Angioscopy | 1 | 2019 | 47 | 0.170 |
Why?
|
Potassium | 1 | 2024 | 1312 | 0.170 |
Why?
|
Follow-Up Studies | 8 | 2024 | 39228 | 0.170 |
Why?
|
Thermometers | 1 | 2019 | 42 | 0.160 |
Why?
|
Atrioventricular Block | 1 | 2021 | 141 | 0.160 |
Why?
|
Prospective Studies | 14 | 2022 | 54807 | 0.160 |
Why?
|
Kidney Diseases, Cystic | 1 | 2020 | 182 | 0.150 |
Why?
|
Retrospective Studies | 22 | 2022 | 81537 | 0.150 |
Why?
|
Heart Failure | 1 | 2023 | 11837 | 0.150 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 26282 | 0.150 |
Why?
|
Titanium | 1 | 2020 | 490 | 0.140 |
Why?
|
Fishes | 1 | 2020 | 607 | 0.140 |
Why?
|
Metabolome | 1 | 2024 | 1005 | 0.140 |
Why?
|
Heart Function Tests | 1 | 2017 | 317 | 0.140 |
Why?
|
Secondary Prevention | 1 | 2023 | 1470 | 0.130 |
Why?
|
Cluster Analysis | 2 | 2021 | 2717 | 0.130 |
Why?
|
Radio Waves | 1 | 2017 | 246 | 0.130 |
Why?
|
Myocardial Revascularization | 1 | 2020 | 795 | 0.130 |
Why?
|
Heart Conduction System | 2 | 2018 | 1007 | 0.130 |
Why?
|
Body Surface Potential Mapping | 1 | 2017 | 228 | 0.130 |
Why?
|
Atrial Flutter | 1 | 2017 | 253 | 0.120 |
Why?
|
Atherosclerosis | 3 | 2021 | 3419 | 0.120 |
Why?
|
Equipment Failure Analysis | 1 | 2017 | 831 | 0.120 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2020 | 855 | 0.120 |
Why?
|
Coronary Thrombosis | 1 | 2017 | 440 | 0.120 |
Why?
|
Coronary Occlusion | 1 | 2017 | 284 | 0.120 |
Why?
|
Sirolimus | 2 | 2018 | 1541 | 0.120 |
Why?
|
Women's Health | 1 | 2024 | 2081 | 0.120 |
Why?
|
Odds Ratio | 3 | 2024 | 9656 | 0.110 |
Why?
|
Materials Testing | 1 | 2018 | 868 | 0.110 |
Why?
|
Aortic Aneurysm, Abdominal | 2 | 2021 | 1248 | 0.110 |
Why?
|
Rupture, Spontaneous | 3 | 2019 | 360 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 3 | 2021 | 6503 | 0.110 |
Why?
|
Ventricular Function, Right | 1 | 2018 | 629 | 0.110 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2023 | 1102 | 0.110 |
Why?
|
Diabetes, Gestational | 1 | 2024 | 1263 | 0.110 |
Why?
|
Cerebral Infarction | 1 | 2018 | 968 | 0.110 |
Why?
|
Constriction, Pathologic | 1 | 2017 | 1102 | 0.110 |
Why?
|
Cause of Death | 1 | 2024 | 3715 | 0.110 |
Why?
|
Electric Impedance | 1 | 2017 | 792 | 0.110 |
Why?
|
Coronary Artery Bypass | 1 | 2022 | 2188 | 0.100 |
Why?
|
Self Report | 1 | 2024 | 3768 | 0.100 |
Why?
|
Contrast Media | 2 | 2016 | 5330 | 0.100 |
Why?
|
Microvessels | 1 | 2016 | 590 | 0.100 |
Why?
|
United States | 3 | 2024 | 72909 | 0.100 |
Why?
|
Lipids | 2 | 2022 | 3317 | 0.100 |
Why?
|
Aorta | 1 | 2019 | 2040 | 0.100 |
Why?
|
Injections, Intraperitoneal | 1 | 2012 | 410 | 0.090 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2012 | 283 | 0.090 |
Why?
|
Life Style | 1 | 2022 | 3928 | 0.090 |
Why?
|
Positive-Pressure Respiration | 1 | 2015 | 712 | 0.090 |
Why?
|
Hyperplasia | 1 | 2013 | 1142 | 0.090 |
Why?
|
Adult | 6 | 2024 | 223088 | 0.090 |
Why?
|
Propensity Score | 1 | 2018 | 1971 | 0.090 |
Why?
|
Dementia | 1 | 2024 | 2741 | 0.080 |
Why?
|
Postoperative Complications | 3 | 2019 | 15802 | 0.080 |
Why?
|
Tunica Intima | 1 | 2012 | 455 | 0.080 |
Why?
|
Tachycardia, Ventricular | 1 | 2018 | 1313 | 0.080 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2013 | 701 | 0.080 |
Why?
|
Linear Models | 1 | 2018 | 5873 | 0.080 |
Why?
|
Cohort Studies | 4 | 2024 | 41680 | 0.080 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12059 | 0.080 |
Why?
|
Incidence | 3 | 2024 | 21513 | 0.070 |
Why?
|
Cytokines | 2 | 2013 | 7417 | 0.070 |
Why?
|
Artifacts | 1 | 2016 | 1896 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2470 | 0.070 |
Why?
|
Dyspnea | 1 | 2015 | 1351 | 0.070 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2013 | 1494 | 0.070 |
Why?
|
Age Factors | 2 | 2021 | 18382 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2013 | 10426 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2018 | 5300 | 0.070 |
Why?
|
Risk Assessment | 4 | 2020 | 24275 | 0.070 |
Why?
|
China | 2 | 2024 | 2383 | 0.060 |
Why?
|
Heart Ventricles | 1 | 2018 | 3833 | 0.060 |
Why?
|
Myocardium | 1 | 2018 | 4764 | 0.060 |
Why?
|
Aspirin | 1 | 2017 | 3135 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4037 | 0.060 |
Why?
|
Regeneration | 1 | 2013 | 1516 | 0.060 |
Why?
|
Blotting, Western | 1 | 2012 | 5019 | 0.060 |
Why?
|
Ultrasonography | 1 | 2017 | 5987 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12529 | 0.060 |
Why?
|
Mice, Inbred C57BL | 2 | 2013 | 22327 | 0.060 |
Why?
|
Algorithms | 1 | 2024 | 14064 | 0.050 |
Why?
|
Body Mass Index | 1 | 2021 | 13042 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2013 | 18292 | 0.050 |
Why?
|
Anticoagulants | 1 | 2018 | 4856 | 0.050 |
Why?
|
Databases, Factual | 4 | 2019 | 8060 | 0.050 |
Why?
|
Prevalence | 4 | 2019 | 15828 | 0.050 |
Why?
|
Disease Progression | 2 | 2021 | 13614 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2022 | 20690 | 0.040 |
Why?
|
Netherlands | 1 | 2024 | 2277 | 0.040 |
Why?
|
Animals | 3 | 2020 | 168735 | 0.040 |
Why?
|
Asia | 1 | 2020 | 630 | 0.040 |
Why?
|
Logistic Models | 3 | 2019 | 13273 | 0.040 |
Why?
|
Macrophages | 1 | 2013 | 5772 | 0.040 |
Why?
|
Aorta, Abdominal | 1 | 2021 | 626 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11030 | 0.040 |
Why?
|
Systole | 1 | 2020 | 935 | 0.040 |
Why?
|
Diastole | 1 | 2020 | 785 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2013 | 18962 | 0.040 |
Why?
|
False Negative Reactions | 1 | 2018 | 570 | 0.030 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2022 | 749 | 0.030 |
Why?
|
Lung | 1 | 2015 | 10046 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2024 | 59496 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2018 | 956 | 0.030 |
Why?
|
Mice | 2 | 2013 | 81782 | 0.030 |
Why?
|
Aortic Aneurysm | 1 | 2020 | 649 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1729 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2024 | 2028 | 0.030 |
Why?
|
Necrosis | 1 | 2018 | 1611 | 0.030 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2020 | 708 | 0.030 |
Why?
|
Prosthesis Failure | 1 | 2017 | 1194 | 0.020 |
Why?
|
Observer Variation | 1 | 2018 | 2611 | 0.020 |
Why?
|
Fibrosis | 1 | 2019 | 2073 | 0.020 |
Why?
|
Action Potentials | 1 | 2019 | 1837 | 0.020 |
Why?
|
Recovery of Function | 1 | 2022 | 2963 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3612 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2017 | 871 | 0.020 |
Why?
|
Heart Rate | 1 | 2019 | 4203 | 0.020 |
Why?
|
Sleep | 1 | 2023 | 4818 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10086 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10611 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2022 | 36547 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16714 | 0.010 |
Why?
|
Thrombosis | 1 | 2017 | 2955 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 3249 | 0.010 |
Why?
|
Pregnancy | 1 | 2024 | 30230 | 0.010 |
Why?
|
Kidney | 1 | 2017 | 7073 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 59857 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22228 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 88811 | 0.010 |
Why?
|
Concepts
(232)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(35)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore